Device
CardioFlux
CardioFlux is a medical device with 7 clinical trials. Historical success rate of 100.0%.
Total Trials
7
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
7
all time
Status Distribution
Completed(3)
Other(4)
Detailed Status
Suspended3
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
7
Active
0
Success Rate
100.0%
Trials by Status
suspended343%
unknown114%
completed343%
Recent Activity
0 active trials
Showing 5 of 7
completed
MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)
NCT06212466
suspended
Magnetocardiography Endocrine Registry
NCT04739254
completed
MCG as a Noninvasive Diagnostic Strategy for Suspected Coronary Microvascular Dysfunction
NCT05150054
unknown
Magnetocardiography as a Noninvasive Diagnostic Strategy for Identifying Coronary Allograft Vasculopathy
NCT05751915
completed
Acute Coronary Syndrome CardioFlux TM Study (ACCMED)
NCT04739267
Clinical Trials (7)
Showing 7 of 7 trials
NCT06212466
MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)
NCT04739254
Magnetocardiography Endocrine Registry
NCT05150054
MCG as a Noninvasive Diagnostic Strategy for Suspected Coronary Microvascular Dysfunction
NCT05751915
Magnetocardiography as a Noninvasive Diagnostic Strategy for Identifying Coronary Allograft Vasculopathy
NCT04739267
Acute Coronary Syndrome CardioFlux TM Study (ACCMED)
NCT05051228
Genetesis Accelerated Registry
NCT04732975
Mason Heart Study With MCG
All 7 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 7